James W. Yockman

2.2k total citations
38 papers, 1.9k citations indexed

About

James W. Yockman is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, James W. Yockman has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 17 papers in Genetics and 7 papers in Surgery. Recurrent topics in James W. Yockman's work include RNA Interference and Gene Delivery (25 papers), Virus-based gene therapy research (17 papers) and Advanced biosensing and bioanalysis techniques (12 papers). James W. Yockman is often cited by papers focused on RNA Interference and Gene Delivery (25 papers), Virus-based gene therapy research (17 papers) and Advanced biosensing and bioanalysis techniques (12 papers). James W. Yockman collaborates with scholars based in United States, South Korea and Netherlands. James W. Yockman's co-authors include Sung Wan Kim, Won Jong Kim, Ji Hoon Jeong, Lane V. Christensen, Yong‐Hee Kim, David A. Bull, Sung Wan Kim, Jan Feijén, Zhiyuan Zhong and Darin Y. Furgeson and has published in prestigious journals such as Biomaterials, Advanced Drug Delivery Reviews and Macromolecules.

In The Last Decade

James W. Yockman

38 papers receiving 1.9k citations

Peers

Countries citing papers authored by James W. Yockman

Since Specialization

Citations

This map shows the geographic impact of James W. Yockman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Yockman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Yockman more than expected).

Fields of papers citing papers by James W. Yockman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James W. Yockman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Yockman. The network helps show where James W. Yockman may publish in the future.

Co-authorship network of co-authors of James W. Yockman

This figure shows the co-authorship network connecting the top 25 collaborators of James W. Yockman. A scholar is included among the top collaborators of James W. Yockman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James W. Yockman. James W. Yockman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cell penetrating peptide conjugated bioreducible polymer for siRNA delivery 2011 ·Biomaterials ·Hye Yeong Nam, Jae‐Sung Kim, Soo‐Jin Kim, James W. Yockman, Sung Wan Kim, David A. Bull	65
2	Bioreducible polymer-conjugated oncolytic adenovirus for hepatoma-specific therapy via systemic administration 2011 ·Biomaterials ·Pyung-Hwan Kim, Jae‐Sung Kim, Tae‐il Kim, Hye Yeong Nam, James W. Yockman, Minjung Kim, Sung Wan Kim, Chae‐Ok Yun	46
3	Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium 2010 ·Biomaterials ·(unknown), Hye Yeong Nam, Mei Ou, Norman Hu, (unknown), James W. Yockman, David A. Bull, Sung Wan Kim	23
4	Dual bio-responsive gene delivery via reducible poly(amido amine) and survivin-inducible plasmid DNA 2010 ·Biotechnology Letters ·Ran Namgung, (unknown), Ji Hoon Jeong, James W. Yockman, Sung Wan Kim, Chao Lin, Zhiyuan Zhong, Jan Feijén, Johan F. J. Engbersen, Won Jong Kim	10
5	Women and heart disease — Physiologic regulation of gene delivery and expression: Bioreducible polymers and ischemia-inducible gene therapies for the treatment of ischemic heart disease 2009 ·Advanced Drug Delivery Reviews ·James W. Yockman, Sung Wan Kim, David A. Bull	6
6	The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy 2009 ·Biomaterials ·Pyung-Hwan Kim, Tae‐il Kim, James W. Yockman, Sung Wan Kim, Chae‐Ok Yun	78
7	Polymer transfected primary myoblasts mediated efficient gene expression and angiogenic proliferation 2009 ·Journal of Controlled Release ·Mei Ou, Tae‐il Kim, James W. Yockman, (unknown), David A. Bull, Sung Wan Kim	22
8	L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL) 2009 ·Journal of Controlled Release ·Young Min Kwon, Hee Soon Chung, Cheol Moon, James W. Yockman, Yoon Jeong Park, Scott D. Gitlin, Allan E. David, Victor C. Yang	106
9	Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction 2008 ·Journal of Controlled Release ·James W. Yockman, Andrew Kastenmeier, (unknown), (unknown), (unknown), (unknown), Dean Y. Li, Sung Wan Kim, David A. Bull	38
10	Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarct 2008 ·Gene Therapy ·James W. Yockman, Donghoon Choi, (unknown), Chien‐Wen Chang, Andrew Kastenmeier, (unknown), (unknown), (unknown), (unknown), David A. Bull	49
11	Non-viral delivery of interleukin-2 and soluble Flk-1 inhibits metastatic and primary tumor growth in renal cell carcinoma 2007 ·Gene Therapy ·James W. Yockman, Woo Jin Kim, Chien‐Wen Chang, (unknown)	9
12	Intracellular Kinetics of Non-Viral Gene Delivery Using Polyethylenimine Carriers 2007 ·Pharmaceutical Research ·(unknown), James W. Yockman, Sung Wan Kim, Steven E. Kern	35
13	Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery 2006 ·Journal of Controlled Release ·Lane V. Christensen, Chien‐Wen Chang, James W. Yockman, (unknown), Heidi H. Jackson, Zhiyuan Zhong, Jan Feijén, David A. Bull, Sung Wan Kim	59
14	Cholesteryl Oligoarginine Delivering Vascular Endothelial Growth Factor siRNA Effectively Inhibits Tumor Growth in Colon Adenocarcinoma 2006 ·Molecular Therapy ·Won Jong Kim, Lane V. Christensen, Seongbong Jo, James W. Yockman, Ji Hoon Jeong, Yong‐Hee Kim, Sung Wan Kim	208
15	Non-ionic amphiphilic biodegradable PEG–PLGA–PEG copolymer enhances gene delivery efficiency in rat skeletal muscle 2006 ·Journal of Controlled Release ·Chien‐Wen Chang, Donghoon Choi, Won Jong Kim, James W. Yockman, Lane V. Christensen, Yong‐Hee Kim, Sung Wan Kim	59
16	Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis 2005 ·Journal of Controlled Release ·Won Jong Kim, James W. Yockman, Minhyung Lee, Ji Hoon Jeong, Yong‐Hee Kim, Sung Wan Kim	113
17	Anti-GAD antibody targeted non-viral gene delivery to islet beta cells 2005 ·Journal of Controlled Release ·Ji Hoon Jeong, Minhyung Lee, Won Jong Kim, James W. Yockman, Tae Gwan Park, Yong‐Hee Kim, Sung Wan Kim	41
18	Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model 2004 ·Molecular Therapy ·Margit M. Janát‐Amsbury, James W. Yockman, Minhyung Lee, Steven E. Kern, Darin Y. Furgeson, Malavosklish Bikram, Sung Wan Kim	74
19	Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment 2004 ·Journal of Controlled Release ·Margit M. Janát‐Amsbury, James W. Yockman, Minhyung Lee, Steven E. Kern, Darin Y. Furgeson, Malavosklish Bikram, Sung Wan Kim	16
20	Tumor regression by repeated intratumoral delivery of water soluble lipopolymers/p2CMVmIL-12 complexes 2003 ·Journal of Controlled Release ·James W. Yockman, Anurag Maheshwari, Sang‐oh Han, Sung Wan Kim	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact